Question

Difficulty: MediumBias, Confounding, and Validity

Below are four distinct methodological observations from recent clinical studies. Pair each specific study finding with the corresponding epidemiological phenomenon that best explains it.

  • Researchers observe an initial positive association between a novel weight-loss medication and incident stroke. However, upon stratifying the subjects by baseline hypertension, the relative risk drops to exactly 1.0 in both the hypertensive and normotensive subgroups.Confounding
  • An evaluation of a new monoclonal antibody for severe asthma demonstrates a reduction in exacerbations overall. Subsequent stratified analysis reveals that the medication drastically reduces exacerbations in patients with elevated eosinophil counts, but has zero effect in patients with normal eosinophil counts.Effect modification
  • During a hospital-based case-control investigation linking artificial sweeteners to gastric cancer, the investigators notice that the newly diagnosed oncology patients spend substantially more effort contemplating and detailing their lifetime dietary habits compared to the healthy volunteers.Recall bias
  • A newly implemented biomarker test identifies pancreatic malignancies much earlier than standard imaging. Patients diagnosed via this biomarker survive an average of 18 months post-diagnosis compared to 12 months for those diagnosed by imaging; however, the absolute population mortality rate for the disease remains completely unchanged.Lead-time bias

Answer

The correct matches map the weight-loss medication scenario to Confounding, the asthma antibody scenario to Effect modification, the gastric cancer scenario to Recall bias, and the pancreatic biomarker scenario to Lead-time bias.
Each observation perfectly aligns with a distinct epidemiological concept. Stratification eliminates confounding but highlights effect modification. Recall bias occurs when diseased individuals reflect on their past differently than healthy controls. Lead-time bias creates the illusion of improved survival due to earlier detection without changing the actual timeline of death.

Step-by-Step Solution

1
Analyze the impact of stratification on the stroke study.
The association disappears across all strata.
To recognize that the initial association was spurious and caused by a third variable, confirming confounding.
2
Analyze the impact of stratification on the asthma therapy study.
The treatment effect size is different depending on the stratum.
To identify that the exposure has a distinct biological effect in different subgroups, confirming effect modification.
3
Assess the behavior of the subjects in the gastric cancer case-control study.
Cases are over-reporting or more accurately reporting past exposures compared to controls.
To correctly diagnose differential information collection, known as recall bias.
4
Evaluate the survival statistics of the new pancreatic cancer screening biomarker.
Apparent survival time from diagnosis increases, but the true population mortality rate is unaffected.
To identify that the screening only pushed the diagnosis date earlier rather than improving treatment outcomes, signifying lead-time bias.

Key Concept

Distinguishing between confounding, effect modification, and specific types of study biases (recall bias, lead-time bias) based on their presentation in clinical trial data.
Rate this question